AI in CGT: genuinely transformative, or the most expensive hype cycle in biotech history?

Beyond the buzzwords: where is AI creating real value in advanced therapies? Artificial intelligence is rapidly becoming embedded across the advanced therapies landscape, from target discovery and process development to manufacturing, clinical development and patient monitoring. Yet amid the enthusiasm, questions remain about where AI is genuinely delivering measurable value and where expectations may be running ahead of reality. This session moved beyond broad predictions and explored practical examples of AI in action. Are companies making better decisions, accelerating development and improving outcomes, or is AI becoming another technology trend that the industry feels compelled to embrace? Through real-world case studies and candid discussion, the panel examined where AI is transforming advanced therapies today, where the evidence remains limited, and what responsible adoption should look like moving forward. 👤 Host: Lee Buckler 👥 Faculty: Claudia Zylberberg & Nina Bauer 👥 Guests: Lara Ionescu Silverman, Irene Rombel & Peggy Bui This Session is sponsored by Autolomous. Season 2 of Advanced Therapies Think Tank is powered and produced by IBTV.